Search for: "Abbott Laboratories, Inc." Results 161 - 180 of 451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2012, 11:45 am
Abbott Laboratories, makers of the drug Depakote, will pay $1.6 billion to settle federal and state claims that it illegally marketed the drug for uses not approved by the Federal Drug Administration. [read post]
15 May 2012, 8:55 am by staff
“Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today. [read post]
9 May 2012, 11:09 am by Seyfarth Shaw LLP
Co-authored by Richard Alfred and Jessica Schauer The Seventh Circuit ruled yesterday that pharmaceutical sales representatives (“PSRs”) for Eli Lilly & Co. and Abbott Laboratories Inc. are exempt from overtime under the Fair Labor Standards Act (“FLSA”) under the Administrative Exemption. [read post]
9 May 2012, 11:09 am by Seyfarth Shaw LLP
Co-authored by Richard Alfred and Jessica Schauer The Seventh Circuit ruled yesterday that pharmaceutical sales representatives (“PSRs”) for Eli Lilly & Co. and Abbott Laboratories Inc. are exempt from overtime under the Fair Labor Standards Act (“FLSA”) under the Administrative Exemption.  [read post]
8 May 2012, 5:03 pm
Yesterday, the Department of Justice announced that Abbott Laboratories Inc. has agreed to plead guilty and pay $1.5 billion to resolve criminal and civil liability resulting from a scheme to promote its prescription drug, Depakote, for uses not approved as safe and effective by the Food and Drug Administration. [read post]
7 May 2012, 10:00 pm by Ben Vernia
On May 7, the Department of Justice announced that Abbott Laboratories, Inc., will pay $1.5 billion to settle civil and criminal allegations involving its anti-seizure drug Depakote. [read post]
7 May 2012, 12:56 pm by Owen Dunn
Whistleblowers have succeeded in a $1.5 billion off-label marketing case against Abbott Laboratories Inc., the Department of Justice announced today. [read post]
29 Mar 2012, 9:55 am by Bexis
Abbott Laboratories, 747 N.Y.S.2d 863, 866 (N.Y. [read post]
22 Mar 2012, 4:24 pm
Abbott Laboratories, Inc. will be reported at CCH Advertising Law Guide ¶64,612. [read post]